Dermal penetration enhancers and drug delivery systems involving the same
DC CAFCFirst Claim
Patent Images
1. A transdermal drug delivery system comprising:
- (a) a therapeutically effective amount of testosterone;
(b) at least one dermal penetration enhancer present in an amount of from 10 to 10,000 wt % based on the weight of the testosterone;
wherein the dermal penetration enhancer is at least one ester of formula (I);
0 Assignments
Litigations
0 Petitions
Accused Products
Abstract
The invention relates to a method for treatment or prophylaxis of a disease or condition in an animal comprising administering to a mucosal membrane of said animal in need of such treatment a therapeutically effective amount of a drug delivery system comprising at least one physiologically active agent or prodrug thereof and at least one penetration enhancer selected from safe ester sunscreens.
117 Citations
13 Claims
-
1. A transdermal drug delivery system comprising:
-
(a) a therapeutically effective amount of testosterone; (b) at least one dermal penetration enhancer present in an amount of from 10 to 10,000 wt % based on the weight of the testosterone;
wherein the dermal penetration enhancer is at least one ester of formula (I); - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)
-
Specification